These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 127400)

  • 1. Proceedings: Observations on fragment D species arising during hydrolysis of crosslinked human fibrin.
    Mosesson MW; Finlayson JS
    Thromb Diath Haemorrh; 1975 Sep; 34(1):328. PubMed ID: 127400
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
    Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W
    Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of fragments E and D on the plasmin hydrolysis of the fibrin clot].
    Lezhen TI; Kudinov SA
    Biokhimiia; 1986 Jun; 51(6):967-9. PubMed ID: 2942191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen assembly and crosslinking on a fibrin fragment E template.
    Mosesson MW; Siebenlist KR; Hernandez I; Wall JS; Hainfeld JF
    Thromb Haemost; 2002 Apr; 87(4):651-8. PubMed ID: 12008948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive exposure of E-neoantigen associated with degradation of crosslinked fibrin by plasmin in vitro.
    Stegnar M; Chen JP
    Thromb Haemost; 1984 Dec; 52(3):315-20. PubMed ID: 6241755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.
    Spraggon G; Everse SJ; Doolittle RF
    Nature; 1997 Oct; 389(6650):455-62. PubMed ID: 9333233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity.
    Dempfle CE; Argiriou S; Alesci S; Kucher K; Müller-Peltzer H; Rübsamen K; Heene DL
    Ann N Y Acad Sci; 2001; 936():210-4. PubMed ID: 11460476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nonenzymatic fibrinolysis].
    Dzhurdzhev A; Atanasov K
    Vutr Boles; 1981; 20(3):18-22. PubMed ID: 6455858
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Characterisation of a soluble high molecular weight e fragment released by plasmin from cross-linked fibrin.
    Lane DA; Brasher M; Kakkar VV; Gaffney PJ
    Thromb Diath Haemorrh; 1975 Sep; 34(1):325. PubMed ID: 127399
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Structural abnormality in the gamma polypeptide chain of Paris I fibrinogen.
    Budzynski AZ; Marder VJ; Ménaché D; Guillin MC
    Thromb Diath Haemorrh; 1975 Sep; 34(1):329. PubMed ID: 1188747
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
    Carroll RC; Lockhart MS; Taylor FB
    J Lab Clin Med; 1984 May; 103(5):695-703. PubMed ID: 6232329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
    Bini A; Itoh Y; Kudryk BJ; Nagase H
    Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen-fibrin degradation products: hemagglutination inhibition immunoassay in plasma.
    Chi DS; Chen JP
    Tex Rep Biol Med; 1975; 33(4):493-508. PubMed ID: 133472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa.
    Siebenlist KR; Meh DA; Wall JS; Hainfeld JF; Mosesson MW
    Thromb Haemost; 1995 Oct; 74(4):1113-9. PubMed ID: 8560422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminology for macromolecular plasmic derivatives of crosslinked fibrin.
    Francis CW; Alkjaersig N; Galanakis DK; Graeff H; Owen J; Gaffney P; Marder VJ
    Thromb Haemost; 1987 Feb; 57(1):110-1. PubMed ID: 2954259
    [No Abstract]   [Full Text] [Related]  

  • 19. gamma-dimerization, alpha-polymerization, and plasmin degradation of human fibrin. Effect of various inhibitors of factor XIII on the patterns in SDS-electrophoresis and crossed immunoelectrophoresis.
    Feddersen JC; Gormsen J
    Thromb Haemost; 1976 Aug; 36(1):27-36. PubMed ID: 137555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.